Viveon Health Acquisition Announces Filing Of Registration Statement On Form S-4 In Connection With Proposed Business Combination With Suneva Medical
Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, and Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative
Viveon Health Acquisition Corp. Reports Received Audit Opinion With Going-Concern Explanation
Viveon Health Acquisition Corp. ("Viveon" or the "Company") (NYSE:VHAQ) today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, which was
Viveon Health Acquisition Announces Clarified Contribution Terms In Connection With The Extension Related To Merger Agreement With Suneva Medical
Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, today announced that it is clarifying certain terms regarding the Annual Meeting
Viveon Health Acquisition Corp. SPAC Merger Partner, Suneva, Reports Surpassed 1M Syringes Of Bellafill Distributed Since Inception
Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, today announced that it
Viveon Health Acquisition Corp. Merger Partner Suneva Medical, Inc. Announces FDA Has Accepted Updates To Plasma IQ Label
Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, today announced that
Regenerative Aesthetics Firm Suneva Medical Gets SPAC Support To Go Public
Suneva Medical Inc, medical aesthetics player, will soon form a